ELEVANCE HEALTH, INC. Gain (Loss) on Sale of Derivatives
ELEVANCE HEALTH, INC. (ELV) reported Gain (Loss) on Sale of Derivatives of $2.10 million for the 12-month period ending 2008-12-31, per its 10-K filed 2011-02-17.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2011-02-17
- ELEVANCE HEALTH, INC. gain (loss) on sale of derivatives for fiscal 2008 was $2.10M.
| Period end | Gain (Loss) on Sale of Derivatives 12 month |
|---|---|
| 2008-12-31 | $2.10M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |